Literature DB >> 11377636

Lotronex and the FDA: a fatal erosion of integrity.

R Horton1.   

Abstract

Keywords:  Health Care and Public Health; Legal Approach

Mesh:

Substances:

Year:  2001        PMID: 11377636     DOI: 10.1016/S0140-6736(00)04776-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  17 in total

1.  Selling drugs to the public--should the UK follow the example of the US?

Authors:  John Frey
Journal:  Br J Gen Pract       Date:  2002-02       Impact factor: 5.386

2.  Selling drugs to doctors--it's marketing, not education.

Authors:  Richelle Cooper; Jerome Hoffman
Journal:  Br J Gen Pract       Date:  2002-02       Impact factor: 5.386

Review 3.  Recent developments in gastroenterology.

Authors:  Paul Moayyedi; Alex Ford
Journal:  BMJ       Date:  2002-12-14

Review 4.  Clinical endpoints in trials of drugs for cancer: time for a rethink?

Authors:  P P Koopmans
Journal:  BMJ       Date:  2002-06-08

Review 5.  Alosetron: a case study in regulatory capture, or a victory for patients' rights?

Authors:  Ray Moynihan
Journal:  BMJ       Date:  2002-09-14

Review 6.  Pharmacology of serotonin: what a clinician should know.

Authors:  F De Ponti
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

7.  Optimizing outcomes with alosetron hydrochloride in severe diarrhea-predominant irritable bowel syndrome.

Authors:  Susan L Lucak
Journal:  Therap Adv Gastroenterol       Date:  2010-05       Impact factor: 4.409

8.  Bias in research and conflict of interest: why should we care?

Authors:  H P Dietz
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-11-21

Review 9.  Drugs and Medical Devices: Adverse Events and the Impact on Women's Health.

Authors:  Jennifer L Carey; Nathalie Nader; Peter R Chai; Stephanie Carreiro; Matthew K Griswold; Katherine L Boyle
Journal:  Clin Ther       Date:  2017-01-07       Impact factor: 3.393

Review 10.  New developments in the diagnosis and treatment of irritable bowel syndrome.

Authors:  George F Longstreth; Douglas A Drossman
Journal:  Curr Gastroenterol Rep       Date:  2002-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.